Shenzhen Kangtai Biological Products Co Ltd
SZSE:300601
Shenzhen Kangtai Biological Products Co Ltd
Cash from Investing Activities
Shenzhen Kangtai Biological Products Co Ltd
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Shenzhen Kangtai Biological Products Co Ltd
SZSE:300601
|
Cash from Investing Activities
-¥827.2m
|
CAGR 3-Years
28%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
N/A
|
|
Beigene Ltd
HKEX:6160
|
Cash from Investing Activities
¥2.4B
|
CAGR 3-Years
-22%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Innovent Biologics Inc
HKEX:1801
|
Cash from Investing Activities
-¥1.1B
|
CAGR 3-Years
41%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Cash from Investing Activities
-¥2.1B
|
CAGR 3-Years
-91%
|
CAGR 5-Years
-42%
|
CAGR 10-Years
N/A
|
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Cash from Investing Activities
-¥993.8m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
-14%
|
|
Imeik Technology Development Co Ltd
SZSE:300896
|
Cash from Investing Activities
-¥943.7m
|
CAGR 3-Years
-233%
|
CAGR 5-Years
-143%
|
CAGR 10-Years
N/A
|
See Also
What is Shenzhen Kangtai Biological Products Co Ltd's Cash from Investing Activities?
Cash from Investing Activities
-827.2m
CNY
Based on the financial report for Sep 30, 2023, Shenzhen Kangtai Biological Products Co Ltd's Cash from Investing Activities amounts to -827.2m CNY.
What is Shenzhen Kangtai Biological Products Co Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
-20%
Over the last year, the Cash from Investing Activities growth was 76%. The average annual Cash from Investing Activities growth rates for Shenzhen Kangtai Biological Products Co Ltd have been 28% over the past three years , -20% over the past five years .